Journal of Antimicrobial Chemotherapy (1999) 43, 637-643
© 1999 The British Society for Antimicrobial Chemotherapy
Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics
a Life Science Research Laboratories, Asahi Chemical Industry Co., Ltd, 632-1 Mifuku, Ohito-cho, Tagata-gun, Shizuoka-ken 410-2321; b Department of Pediatrics, Yamanashi Red Cross Hospital, 6663-1 Funazu, Kawaguchiko-mati, Minamituru-gun, Yamanasi-ken; c Chemotherapy for Mothers and Children Research Institute, 2-55-12 Ikebukuro, Tosimaku, Tokyo, Japan
From February to October 1995, 62 erythromycin-resistant strains of Streptococcus pneumoniae isolated at Yamanashi Red Cross Hospital were tested to determine their susceptibility to various macrolides, subjected to resistance induction tests by the disc diffusion method and analysed for genes encoding resistance to macrolides (ermB and mefE). On the basis of resistance induction testing, the isolates were classified as having either inducible (59.7%) or non-inducible (40.3%) macrolide resistance. The ermB gene was always detected in resistance-inducible type isolates, either alone or in combination with mefE. The mefE gene alone was found only in non-inducible type isolates. Isolates with non-inducible resistance (those with only the mefE gene) had an intermediate level of resistance to 14-membered macrolides, and were susceptible to rokitamycin, a 16-membered macrolide. According to NCCLS guidelines, 9.6% of S. pneumoniae strains were judged to be susceptible to penicillin, 62.9% of reduced susceptibility and 27.4+ penicillin resistant. No correlation was detected between the presence of particular macrolide-resistance genes (ermB, ermB + mefE, or mefE) and resistance to penicillin G.
* Tel: +81-558-76-7083; Fax: +81-558-76-2947; E-mail: a9086692{at}genji.ut.asahi-kasei.co.jp
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. H. W. Klaassen and J. W. Mouton Molecular Detection of the Macrolide Efflux Gene: To Discriminate or Not To Discriminate between mef(A) and mef(E) Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1271 - 1278. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kasahara, K. Maeda, K. Mikasa, K. Uno, K. Takahashi, M. Konishi, E. Yoshimoto, K. Murakawa, E. Kita, and H. Kimura Clonal Dissemination of Macrolide-Resistant and Penicillin-Susceptible Serotype 3 and Penicillin-Resistant Taiwan 19F-14 and 23F-15 Streptococcus pneumoniae Isolates in Japan: a Pilot Surveillance Study J. Clin. Microbiol., April 1, 2005; 43(4): 1640 - 1645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Brown, D. J. Farrell, and I. Morrissey Prevalence and Molecular Analysis of Macrolide and Fluoroquinolone Resistance among Isolates of Streptococcus pneumoniae Collected during the 2000-2001 PROTEKT US Study J. Clin. Microbiol., November 1, 2004; 42(11): 4980 - 4987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. Waites, K. E. Jones, K. H. Kim, S. A. Moser, C. N. Johnson, S. K. Hollingshead, E.-S. Kang, K. S. Hong, and W. H. Benjamin Jr. Dissemination of Macrolide-Resistant Streptococcus pneumoniae Isolates Containing Both erm(B) and mef(A) in South Korea J. Clin. Microbiol., December 1, 2003; 41(12): 5787 - 5791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Danesi, A. Lupetti, C. Barbara, E. Ghelardi, A. Chella, T. Malizia, S. Senesi, C. A. Angeletti, M. Del Tacca, and M. Campa Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg J. Antimicrob. Chemother., April 1, 2003; 51(4): 939 - 945. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Neuhauser, J. L. Prause, L. H. Danziger, and S. L. Pendland In Vitro Bactericidal Activities of ABT-773 against ermB Strains of Streptococcus pneumoniae Antimicrob. Agents Chemother., March 1, 2003; 47(3): 1132 - 1134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Montanari, M. Mingoia, I. Cochetti, and P. E. Varaldo Phenotypes and Genotypes of Erythromycin-Resistant Pneumococci in Italy J. Clin. Microbiol., January 1, 2003; 41(1): 428 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-A. Lim, A.-R. Kwon, S.-K. Kim, Y. Chong, K. Lee, and E.-C. Choi Prevalence of resistance to macrolide, lincosamide and streptogramin antibiotics in Gram-positive cocci isolated in a Korean hospital J. Antimicrob. Chemother., March 1, 2002; 49(3): 489 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Canu, B. Malbruny, M. Coquemont, T. A. Davies, P. C. Appelbaum, and R. Leclercq Diversity of Ribosomal Mutations Conferring Resistance to Macrolides, Clindamycin, Streptogramin, and Telithromycin in Streptococcus pneumoniae Antimicrob. Agents Chemother., January 1, 2002; 46(1): 125 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. B. Hyde, K. Gay, D. S. Stephens, D. J. Vugia, M. Pass, S. Johnson, N. L. Barrett, W. Schaffner, P. R. Cieslak, P. S. Maupin, et al. Macrolide Resistance Among Invasive Streptococcus pneumoniae Isolates JAMA, October 17, 2001; 286(15): 1857 - 1862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Fluit, M. R. Visser, and F.-J. Schmitz Molecular Detection of Antimicrobial Resistance Clin. Microbiol. Rev., October 1, 2001; 14(4): 836 - 871. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-I. Morosini, R. Canton, E. Loza, M.-C. Negri, J.-C. Galan, F. Almaraz, and F. Baquero In Vitro Activity of Telithromycin against Spanish Streptococcus pneumoniae Isolates with Characterized Macrolide Resistance Mechanisms Antimicrob. Agents Chemother., September 1, 2001; 45(9): 2427 - 2431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Rodriguez-Avial, C. Rodriguez-Avial, E. Culebras, A. Benitez, and J. J. Picazo Distribution of mef(A) and erm(B) genes in macrolide-resistant blood isolates of viridans group streptococci J. Antimicrob. Chemother., May 1, 2001; 47(5): 727 - 728. [Full Text] [PDF]
|
|
|
|
|
|
L. McGee, K. P. Klugman, A. Wasas, T. Capper, A. Brink, and The Antibiotics Surveillance Forum Of South Africa Serotype 19F Multiresistant Pneumococcal Clone Harboring Two Erythromycin Resistance Determinants [erm(B) and mef(A)] in South Africa Antimicrob. Agents Chemother., May 1, 2001; 45(5): 1595 - 1598. [Abstract] [Full Text]
|
|
|
|
|
|
M. P. Montanari, M. Mingoia, E. Giovanetti, and P. E. Varaldo Differentiation of Resistance Phenotypes among Erythromycin-Resistant Pneumococci J. Clin. Microbiol., April 1, 2001; 39(4): 1311 - 1315. [Abstract] [Full Text]
|
|
|
|
|
|
H. Okamoto, S. Miyazaki, K. Tateda, Y. Ishii, and K. Yamaguchi Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against Gram-positive clinical isolates in Japan J. Antimicrob. Chemother., November 1, 2000; 46(5): 797 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Betriu, M. Redondo, M. L. Palau, A. Sánchez, M. Gómez, E. Culebras, A. Boloix, and J. J. Picazo Comparative In Vitro Activities of Linezolid, Quinupristin-Dalfopristin, Moxifloxacin, and Trovafloxacin against Erythromycin-Susceptible and -Resistant Streptococci Antimicrob. Agents Chemother., July 1, 2000; 44(7): 1838 - 1841. [Abstract] [Full Text]
|
|
|
|
|
|
K. Waites, C. Johnson, B. Gray, K. Edwards, M. Crain, and W. Benjamin Jr. Use of Clindamycin Disks To Detect Macrolide Resistance Mediated by ermB and mefE in Streptococcus pneumoniae Isolates from Adults and Children J. Clin. Microbiol., May 1, 2000; 38(5): 1731 - 1734. [Abstract] [Full Text]
|
|